

On completion of this activity, participants should be able to:
Recognize the clinical presentations of chronic inflammatory demyelinating polyneuropathy (CIDP), multifocal motor neuropathy (MMN), Guillain-Barré syndrome (GBS), and myasthenia gravis (MG)
Evaluate the diagnostic evidence of CIDP, MMN, GBS, and MG
Outline appropriate therapy based on disease course, therapeutic mechanisms, and safety and efficacy data
Determine the appropriate timing, dosage, and duration of specific therapies used in the treatment of autoimmune muscular disease based on available evidence and expert opinion

The goal of this activity is to assist participants in the diagnosis and treatment of autoimmune neuromuscular diseases by increasing knowledge and competence in the performance and interpretation of electrodiagnostic studies, differential diagnosis, and treatment options.
CME Accreditation Statement
DIME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


This activity is not part of the official scientific program of the AANEM.
Chairperson:
Carol Lee Koski, MD
Faculty:
Marinos C. Dalakas, MD, FAAN
Gil I. Wolfe, MD

